These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32898255)

  • 1. Usefulness of post-procedural heart rate response to predict syncope recurrence or positive head up tilt table testing after cardioneuroablation.
    Aksu T; Guler TE; Bozyel S; Yalin K; Gopinathannair R
    Europace; 2020 Sep; 22(9):1320-1327. PubMed ID: 32898255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of aging on outcomes of cardioneuroablation for reflex syncope or functional bradycardia: Results from the cardionEuroabLation: patiEnt selection, imaGe integrAtioN and outComEs-The ELEGANCE multicenter study.
    Francia P; Viveros D; Falasconi G; Penela D; Soto-Iglesias D; Martí-Almor J; Alderete J; Saglietto A; Bellido AF; Franco-Ocaña P; Zaraket F; Matiello M; Fernández-Armenta J; San Antonio R; Berruezo A
    Heart Rhythm; 2023 Sep; 20(9):1279-1286. PubMed ID: 37329936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benefit of cardioneuroablation to reduce syncope recurrence in vasovagal syncope patients: a case-control study.
    Aksu T; Padmanabhan D; Shenthar J; Yalin K; Gautam S; Valappil SP; Banavalikar B; Guler TE; Bozyel S; Tanboga IH; Lakkireddy D; Olshansky RB; Gopinathannair R
    J Interv Card Electrophysiol; 2022 Jan; 63(1):77-86. PubMed ID: 33527216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope.
    Tu B; Wu L; Hu F; Fan S; Liu S; Liu L; Ding L; Zheng L; Yao Y
    Heart Rhythm; 2022 Apr; 19(4):562-569. PubMed ID: 34896621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioneuroablation changes the type of vasovagal response in patients with asystolic reflex syncope.
    Piotrowski R; Żuk A; Baran J; Sikorska A; Kryński T; Kułakowski P
    Auton Neurosci; 2021 Nov; 235():102838. PubMed ID: 34186273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tilt training in patients with vasovagal syncope.
    Gajek J; Zyśko D; Mazurek W
    Kardiol Pol; 2006 Jun; 64(6):602-8; discussion 609-10. PubMed ID: 16810579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinician needs and perceptions about cardioneuroablation for recurrent vasovagal syncope: An international clinician survey.
    Vandenberk B; Morillo CA; Sheldon RS; Chew DS; Aksu T; Raj SR
    Heart Rhythm; 2021 Dec; 18(12):2160-2166. PubMed ID: 34419666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An implantable loop recorder study of highly symptomatic vasovagal patients: the heart rhythm observed during a spontaneous syncope is identical to the recurrent syncope but not correlated with the head-up tilt test or adenosine triphosphate test.
    Deharo JC; Jego C; Lanteaume A; Djiane P
    J Am Coll Cardiol; 2006 Feb; 47(3):587-93. PubMed ID: 16458141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation of severe neurally meditated reflex (neurocardiogenic or vasovagal) syncope: cardioneuroablation long-term results.
    Pachon JC; Pachon EI; Cunha Pachon MZ; Lobo TJ; Pachon JC; Santillana TG
    Europace; 2011 Sep; 13(9):1231-42. PubMed ID: 21712276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: a prospective and randomized study.
    Duygu H; Zoghi M; Turk U; Akyuz S; Ozerkan F; Akilli A; Erturk U; Onder R; Akin M
    Pacing Clin Electrophysiol; 2008 May; 31(5):592-6. PubMed ID: 18439174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved health-related quality of life after cardioneuroablation in patients with vasovagal syncope.
    Baysal E; Mutluer FO; Dagsali AE; Kumrulu UC; Huang HD; Aksu T
    J Interv Card Electrophysiol; 2022 Nov; ():. PubMed ID: 36357697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrate-potentiated head-up tilt testing (HUT) has a low diagnostic yield in patients with likely vasovagal syncope.
    Petix NR; Del Rosso A; Furlan R; Guarnaccia V; Zipoli A
    Pacing Clin Electrophysiol; 2014 Feb; 37(2):164-72. PubMed ID: 23992559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study.
    Russo V; Rago A; Papa AA; Golino P; Calabrò R; Russo MG; Nigro G
    Heart; 2013 Nov; 99(21):1609-13. PubMed ID: 23723446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioinhibitory syncope: from pathophysiology to treatment-should we think on cardioneuroablation?
    Garcia A; Marquez MF; Fierro EF; Baez JJ; Rockbrand LP; Gomez-Flores J
    J Interv Card Electrophysiol; 2020 Nov; 59(2):441-461. PubMed ID: 32377918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate recovery and diastolic blood pressure ratio on the treadmill test predict an induction and recurrence of vasovagal syncope.
    Choi YJ; Kang KW; Jang SH; Kim JG; Lee SJ; Jung KT
    Korean J Intern Med; 2019 Mar; 34(2):315-323. PubMed ID: 29240992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioneuroablation for Cardioinhibitory Vasovagal Syncope: Rationale, Approaches, and Its Role in Long-Term Management.
    Aksu T; Chung MK
    Curr Cardiovasc Risk Rep; 2024 Apr; 18(4):55-64. PubMed ID: 38707611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators.
    Sutton R; Brignole M; Menozzi C; Raviele A; Alboni P; Giani P; Moya A
    Circulation; 2000 Jul; 102(3):294-9. PubMed ID: 10899092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioneuroablation as a strategy to prevent pacemaker implantation in young patients with vasovagal syncope.
    Joza J; Gustavo Bravosi da Rosa L; Alturki A; Anglesio V; Sanchez-Somonte P; Poletaev V; Bernier M; Verma A; Essebag V
    Int J Cardiol Heart Vasc; 2024 Apr; 51():101360. PubMed ID: 38379634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioneuroablation for severe neurocardiogenic syncope.
    Santos Silva G; Fonseca P; Cardoso F; Almeida J; Ribeiro S; Oliveira M; Sanfins V; Gonçalves H; Pachon M JC; Barra S; Primo J; Lourenço A; Fontes-Carvalho R
    Rev Port Cardiol; 2023 Oct; 42(10):821-829. PubMed ID: 37268266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deceleration capacity-a novel measure for autonomic nervous system in patients with vasovagal syncope on tilt-table testing.
    Huang F; Xu CF; Deng XY; Zuo P; Lin F; Fan JJ; Xu WJ; Yang XY
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):326-331. PubMed ID: 28585146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.